European Archives - Page 5 of 1530 - European Medical Journal

Primary Cardiac Involvement in Early Systemic Sclerosis

Primary cardiac involvement (pCI) is a major contributor to morbidity and mortality in systemic sclerosis (SSc). In routine practice…

Improving Medication Safety in Primary Care Using eDoseCKD

Chronic kidney disease (CKD) affects 10% of the global population. Medication dosing errors in people with impaired kidney function are…

Highlights from the EULAR 2026 Congress

Loss of B cell tolerance emerged as an early driver of systemic autoimmunity in both SLE and RA.1 Bylinska et al.1 profiled the…

Gastrointestinal Involvement in Systemic Sclerosis

Two large cohorts converged on early prediction. In the GENISOS cohort, Ayla et al.1 followed 450 patients with early SSc (≤5 years from…

Assisted Peritoneal Dialysis: A Missed Opportunity in Integrated Care for Patients on Dialysis

AT THE EUROPEAN Renal Association (ERA) 2026 Congress, Irma Tchokhonelidze, Tbilisi State Medical University, Georgia, presented a…

Management of Glomerulonephritis

Glomerulonephritis is a complex group of immune-mediated kidney diseases with diverse causes and presentations. This infographic provides…

Caregiver Acceptance-Focused Coping Buffers Anxiety Transmission in Haemodialysis Dyads

Haemodialysis is associated with substantial psychological burden for both patients and their family caregivers. Preliminary findings of…

One-year Changes of Spinal New Bone Formation in Axial Spondyloarthritis

Structural damage, particularly new bone formation (NBF) and progression thereof in the spine, is a well-recognised feature of axial…

L-Tartaric Acid Benefits Diabetic Cardiomyopathy – EMJ

L-Tartaric Acid Shows Promise for Diabetic Cardiomyopathy

Pre-clinical trials showed long-term L-tartaric acid treatment improved cardiac function and was associated with reduced inflammation, oxidative stress, and apoptosis in diabetic cardiomyopathy.

Trauma Therapy Reduces PTSD in Psychosis - EMJ

New Therapy Reduces PTSD Symptoms in People with Psychosis

A UK trial shows trauma-focused therapy safely and effectively reduces PTSD symptoms in people living with psychosis.